Talk to Your Healthcare Team About Kitabis Pak
If you are currently taking nebulized tobramycin as part of your treatment regimen (or have been instructed that you will need to in the future), talk to your doctor or healthcare team member about the option of Kitabis Pak.
Because Kitabis Pak includes both the drug and the device to deliver it, it is often a simpler option for patients. No hassle with device co-pays, co-insurance, deductibles, or other treatment delays. One prescription, one stop.*
Available Through Specialty Distributors
We have established a network of partner pharmacies throughout the US that will provide patient access to Kitabis Pak and ensure it’s delivered directly to the user. Drug. Device. Delivered.
Bogart, GA 30622
Lubbock, TX 794109
Earth City, MO 63045
Orlando, Fl 32822
West Allis, WI 53214
Taylorsville, UT 84123
Flint, MI 48507
Sioux Falls, SD 57104Walgreens Locations::
Frisco, TX 75034
Frisco, TX 75034
Carnegie, PA 15106
Beaverton, OR 97008
Canton, MI 48188
Boston, MA 02116
Aurora, CO 80045
Palo Alto, CA 94301
New York, NY 10011Walgreens Locations:
For reference, when contacting these partners:
Kitabis Pak Part Number: 850F5601
IMPORTANT: Only the specific Walgreens locations listed above distribute Kitabis Pak.
If you need more information about Kitabis Pak, where to find it, or how to take it – please request more information using our email contact form.
*Also requires use of compressor. Compressor not included in Kitabis Pak. See Package Insert for details.
Kitabis Pak (co-packaging of tobramycin inhalation solution and a PARI LC PLUS Reusable Nebulizer) is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with P. aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia.
Important Safety Information
Do not take Kitabis Pak (Tobramycin Inhalation Solution) if you are allergic to tobramycin, or any of the ingredients in Kitabis Pak, or any aminoglycocide antibiotic.
Before taking Kitabis Pak, inform your health care provider if you have or have had any hearing problems including ringing or other noises in your ears, dizziness, kidney problems, muscle weakness such as myasthenia gravis or Parkinson’s disease, breathing problems such as wheezing, coughing or chest tightness, or have had an organ transplant. Before you inhale Kitabis Pak, inform your health care provider if you are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed. It is not known if Kitabis Pak will pass into breast milk.
Tell your health care provider about all the medicines you take. Taking Kitabis Pak with certain other medications can cause serious side effects. If you are taking Kitabis Pak, you should discuss with your health care provider if you should take other medicines that may harm your nervous system, kidneys or hearing, or diuretics (water pills) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), mannitol, or urea.
Kitabis Pak can cause serious side effects including hearing loss or ringing in the ears (ototoxicity), worsening kidney problems (nephrotoxicity), worsening muscle weakness, harm to an unborn baby, and/or severe breathing problems (bronchospasm). Tell your health care provider right away of you have hearing loss or hear noises in your ears (such as ringing or hissing), develop vertigo, dizziness, difficulty with balance, shortness of breath with wheezing, or coughing or chest tightness. Your health care provider may do a blood test and urine test to check how your kidneys are working while you are taking Kitabis Pak.
The most common side effects of Kitabis Pak include cough, sore throat, productive cough, shortness of breath, coughing up blood, worsening of lung problems or cystic fibrosis, changes in your voice (hoarseness), altered taste, and rash. Tell your health care provider about any side effect that bothers you or that does not go away.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This web site is intended for United States residents only.